Agilon Health (NYSE:AGL) Trading 12.6% Higher – Should You Buy?

Agilon Health, Inc. (NYSE:AGL)’s stock price traded up 12.6% during trading on Thursday . The stock traded as high as $93.79 and last traded at $93.1160. 49,253 shares traded hands during trading, a decline of 86% from the average session volume of 357,793 shares. The stock had previously closed at $82.70.

Wall Street Analyst Weigh In

Several analysts have recently commented on AGL shares. Barclays upgraded shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price objective on the stock in a research report on Tuesday, May 26th. Robert W. Baird upped their price target on shares of Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft raised Agilon Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $33.00 to $49.00 in a research note on Thursday, May 7th. JPMorgan Chase & Co. downgraded Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective on the stock. in a research report on Monday, May 4th. Finally, Weiss Ratings downgraded Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 27th. Five research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $58.73.

Agilon Health Trading Up 17.3%

The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The company’s fifty day moving average is $44.12 and its 200-day moving average is $26.41. The stock has a market cap of $1.62 billion, a PE ratio of -4.48 and a beta of 3.02.

Agilon Health (NYSE:AGL) last issued its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The firm had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.38 billion. On average, analysts predict that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Hedge funds have recently added to or reduced their stakes in the business. North Peak Capital Management LLC grew its position in shares of Agilon Health by 10.8% in the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after buying an additional 3,715,460 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Agilon Health by 196.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock worth $13,812,000 after purchasing an additional 13,283,930 shares during the last quarter. CenterBook Partners LP increased its position in Agilon Health by 492.4% during the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after purchasing an additional 9,499,012 shares during the last quarter. AQR Capital Management LLC increased its position in Agilon Health by 1,346.6% during the fourth quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after purchasing an additional 9,505,837 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Agilon Health by 30.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company’s stock worth $5,523,000 after purchasing an additional 1,893,434 shares during the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.